Moreover, studies have shown that PRC1 is associated with poor prognosis in lung adenocarcinoma, and thus inhibition of PRC1 may be a promising therapeutic target for lung adenocarcinoma (Chen et al., 2016). Here, PRC1 is linked to lung adenocarcinoma.